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Angiotensin-Converting Enzyme:
II. Pulmonary Endothelial Cells
in Culture
by Una S. Ryan* and James W. Ryan*
Direct studies of the function of a given cell type often require that the cell type be obtained in pure
culture. A number ofdifferent specific metabolic activities have been attributed to pulmonary endothelial
cells, yetwithfew exceptions theconclusions were basedon indirect evidence. Thus, toimprove our ability
to examine directly for specific metabolic activities, we began a program to obtain pulmonary endothelial
cells in culture. Two methods have been developed: (1) cells can be obtained from pulmonary artery and
vein oflarge animals (cow, pig), and (2) cells can be obtained from the microvasculature ofsmall animals
(rat, guinea pig, and rabbit). The lattertechnique can also be used to obtain cells from a lobe oflungfrom
large animals and may be adaptablefor use withhuman tissue. In the first technique, pulnonary arteries,
free of blood, are filled with collagenase (0.25%, 500 units) in Puck's saline for 25 min. The collagenase
mixture containing cells is removed and centrifuged. The pellet is resuspended and seeded into culture
flasks. In the second method, lungs are perfused (artery to vein) with Krebs-Henseleit solution until the
effluent is blood-free. Collagenase (0.25%, 500 units) is introduced, and the lungs are then perfused in the
opposite direction (vein to artery) until the flow stops spontaneously (ca. 15 min). The detached cells are
collected andseeded asbefore. Theendothelinl cellsattachassmallclumps(10-50cells). Thoseflaskswhich
contain more than 95% endothelial cells (by phase microscopy) are retained for culture and the lines are
purified usingdifferential adherence procedures. Thecells grow asmonolayers with acobblestone appear-
ance. They contain Weibel-Palade bodies. They possess converting enzyme activity and are reactive with
antibodies to converting enzyme, Factor VIII and a2-macroglobulin. The cells synthesize prostaglandins
and related substances. In addition, they possess ADPase and synthesize angiotensin-converting enzyme.
Introduction
One ofthe technical limitations to progress in un-
derstanding of specific functions of a particular cell
type is the availability of that cell type in pure cul-
ture. Over the past 12 years, a number of different
specific metabolic activities have been attributed to
pulmonary endothelial cells. The cells can selec-
tively process adenine nucleotides and biogenic
amines (1, 2). In addition, endothelial cells are capa-
ble offorming prostaglandins such as PGE2 (3-5) and
PGI2 (6, 7). Endothelial cells appear to have a great
capacity for inactivating kinins and for converting
angiotensin I into angiotensin 11 (3, 8), and in this
sense endothelial cells of the pulmonary vascular
bed can regulate the hormonal composition of sys-
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temic arterial blood. In addition, endothelial cells
appear to possess a number of hemostatic factors
including a2-macroglobulin (9), plasminogen ac-
tivator (10) and factor VIII antigen (11).
By and large, metabolic activities attributed to
pulmonaiy endothelium were based on conclusions
drawn from indirect evidence. Perhaps the most di-
rect method forexamining for unique or characteris-
tic properties ofa given line ofendothelial cells is to
use isolated cells (12-14) or cells in culture. Others
have developed methods for isolating and culturing
endothelial cells from human umbilical vein (15-18).
Similar techniques have been used to isolate and
culture endothelial cells from portal vein and aorta
(19-23). Therefore to improve our ability to examine
directly for specific metabolic activities of pulmo-
nary endothelium, we have begun a program to ob-
tain pulmonary endothelial cells in culture. Two
methods have been developed: cells can be obtained
from pulmonary artery and vein of large animals
171(cow and pig); alternatively cells can be obtained
from the microvasculature of small animals (rats,
guinea pig and rabbit), animals used commonly in
studies of "nonventilatory functions" of the lungs.
The latter technique can also be used to obtain cells
from a lobe of lung from large animals and may be
adaptable for use with human tissue obtained by
open biopsy.
Materials and Methods
Isolation and Culture of Pulmonary Artery
Endothelial Cells
Pulmonary arteries from newborn or unweaned
calf (veal) are obtained within 30 min of slaughter.
Calf hearts with attached great vessels are trans-
ported at 4°C to the laboratory where they are rinsed
with Puck's saline. Each pulmonary artery is sepa-
rated from the aorta and trimmed of excess fat and
connective tissue. The pulmonary artery is tied as
close to the heart as possible and the vessel is re-
moved. Each vessel is washed by immersion inthree
changes of Puck's saline containing 3x strength an-
tibiotics (Biostat 100, 3 mlI.). When all ofthe ves-
sels have been trimmed and washed, they are placed
in a beaker of Puck's saline with 3x antibiotics and
stored at 4°C for approx. 90 min. This storage step
appears to reduce the likelihood of subsequent
bacterial contamination. The vessel segments are
then warmed to 37°C in a shaking waterbath. Each
pulmonary artery segment isdrained ofexcess saline
and filled with a solution of 0.25% collagenase
(Worthington type CLS II) in Puck's saline contain-
ing normal strength antibiotics (Biostat 100, 1 ml/l.).
The free end of each artery is then clamped with a
large hemostat. The arteries are suspended in a 2 1.
beakerofphosphate buffered saline and incubated at
37°C in a shaking waterbath for 25 min. The arteries
are then removed and the exteriors blotted dry on
sterile tissue. Each artery is then suspended by the
ligature over a small beaker or centrifuge tube and
the hemostat is released. The collagenase mixture
containing cells is decanted into 15ml tubes and cen-
trifuged at 750g for 10 min at4°C. The supernatant is
discarded and the pellets washed by resuspending
and repelleting twice with cold medium 199 (without
fetal calf serum). The final pellets are then resus-
pended in 1 ml of medium 199 and seeded into
25 cm2 tissue culture flasks containing 4 ml of
medium 199 with 20% fetal calf serum and normal
strength (1 ml/l.) Biostat 100. The flasks are capped
loosely and placed in a C02 (5%) incubator at 37°C.
The cells show the greatest plating efficiency when
seeded as small clumps rather than as monodisper-
sions. Therefore, hemocytometer counts may not be
accurate. However, cells seeded at densities of ap-
prox. 1.5-3 x 105 perflask reach confluency within 5
days. At confluence, the cells reach a density of
about 4 x 104/cm2 (106 per flask). The medium is
changed every two days.
The cells canbe subcultured asfollows: Flasks are
washed for approx. 10 min with 5 ml of Ca2+- and
Mg2+-free Puck's saline at 37°C. The saline wash is
aspirated off and the cells are incubated with 0.05%
trypsin with 0.02% EDTA in Ca2+- and Mg2+-free
Puck's saline (5 ml at 37°C). The cells are monitored
on an inverted microscope to determine the optimal
length of time of exposure to the trypsin-EDTA so-
lution. We have found that after 3 min the small,
polygonal endothelial cells begin to liftoff, while the
larger, flatter smooth muscle cells are still adherent
to the flask. With a minimum of agitation, the en-
zyme mixture containing cells is transferred, by
using a 5 ml pipet, to 15 ml conical centrifuge tubes.
The cells are centrifuged at 750g for 10 min. The
trypsin solution is removed by aspiration and the
pellet is resuspended in a small quantity of medium
199 without fetal calf serum. The flasks are usually
split two for one. Each new flask is seeded with
approximately 105 cells. The doubling time for
bovine pulmonary artery endothelial cells is ap-
proximately 24 hr. Flasks which are predominantly
endothelial (less than5%contamination with smooth
muscle cells) can be purified by successive subcul-
ture; taking advantage of the difference in attach-
ment and detachment rates of the two cell types.
Trypsin preferentially detaches bovine endothelial
cells; thus, short periods (2 to 3 min) ofexposure to
trypsin prior to transferring cells tend to leave
smooth muscle cells adherent to the flasks. Further-
more, endothelial cells are the first to reattach.
Hence, cells are seeded into new flasks and incu-
bated for 1 hr at 37°C. Medium and any free-floating
cells are removed by aspiration and replaced with
fresh medium containing fetal calf serum and an-
tibiotics.
Isolation and Culture of Endothelial Cells
From the Lungs of Small Animals
The techniques described above for the isolation
and culture ofendothelial cells obtainedfrombovine
pulmonary artery have provided useful information
on specific metabolic activities of pulmonary en-
dothelium (3). The techniques are not however suit-
able for obtaining endothelial cells from the vessels
of small animals or from the microvasculature. We
have, therefore, developed atechniqueforobtaining
endothelial cells from the lungs by vascular perfu-
sion with collagenase in a Hepes buffered salt solu-
Environmental Health Perspectives 172tion. The surgical procedure and techniques for col-
lection of cells are similar using rats, rabbits or
guinea pigs of either sex (Fig. 1).
Thefollowingdescribes the perfusion system used
with afemale NewZealandwhite rabbitof2.16 kg. A
tracheostomy was performed and a tracheal tube
I11
was inserted, secured with aligature and attached to
a Harvard respirator (tidal volume 18 ml, 45 strokes
per minute, inspiration to expiration ratio of 0.45).
Heparin (5,000 units) was injected intravenously.
Ligatures were placed around the pulmonary artery
and around the left atrium so as to create a venous
Catheter into
pulmonary ye:
...... ..
FIGURE 1. Perfusion system for rendering lungs free of blood and treating the microvasculature with
collagenase to allow collection of endothelial cells. The perfusion system is described in the text.
Small gauge catheters are inserted and tied into the pulmonary artery and pulmonary vein sinus.
Saline is perfused in aforward direction (artery tovein) until theeffluent isfree ofblood. Perfusion of
enzyme is from the venous to the arterial side; a maneuver accomplished by connecting the drain
cannula (in the pulmonary vein) to the enzyme stopcock and by disconnecting the cannula to the
pulmonary artery from the saline stopcock. The free end ofthe arterial cannula is then directed to a
collection tube.
April 1980 173sinus into which all pulmonary veins drained. The
saline perfusion system was opened to the arterial
catheter. The pulmonary artery was opened and the
catheter was inserted and secured with a ligature. A
hole was immediately cut in the right ventricle for
drainage; a hole was also cut in the left ventricle and
adrain catheterwas inserted throughthemitral valve
and into the atrium and secured with a ligature. The
perfusion solution was pumped for 5 to 10 min, at
which time the effluent was clear and colorless.
When the lungs became white and their venous
effluent was free ofblood, the collagenase stopcock
was opened, the respirator was turned off and the
trachea was clamped. The free end ofthe pulmonary
vein catheter was attached to the collagenase stop-
cock. The pulmonary artery catheter was detached
from the saline perfusion system and directed to a
cell collection tube. Thus, retrograde perfusion of
the lungs was established. The free end of the pul-
monary artery catheter was directed into a sterile
15 ml centrifuge tube to collect the cell-enzyme sus-
pension. Perfusion with collagenase was continued
until the lungs became edematous and flow stopped
spontaneously. The collection tubes were cen-
trifuged for 10 min at 750g. The supernatant was
removed by aspiration, and each pellet was resus-
pended in 10 ml of 0.01 Hepes buffered saline,
pH 7.4. The tubes were centrifuged again and the
supernatant was discarded. The pellets were resus-
pended in 1 ml ofmedium 199 using a Vortex mixer.
Corning tissue culture flasks, 25 cm2 werefilled with
4 ml of medium 199 containing 20%o fetal calf serum
and antibiotics. Each culture flask was seeded with
1 ml of suspension and the flasks were incubated at
37°C in 100% humidity in a5% C02 atmosphere. The
numberofcells seeded perflask is approx. 2.8 x 105.
However, the seeding density cannot be determined
accurately since the cells are removed as clumps or
sheets, not as a monodispersion and because blood
cells are present (and beneficial) in the original iso-
late. Those flasks which contain more than 95% en-
dothelial cells (asjudged by phase contrast micros-
copy) are retained for culture and the lines are
purified overthe nextfew passages using differential
adherence procedures as described above.
Results and Discussion
Identification of Endothelial Cells
Cells obtained by either method are readily identi-
fiable as endothelial using morphological and func-
tional criteria. When examined in the inverted mi-
croscope by phase contrast microscopy the cells
grow as monolayers with a cobblestone appearance
characteristic of endothelium (Figs. 2 and 3). When
examined in the electron microscope, they contain
all of the cellular organelles expected of pulmonary
artery endothelial cells in situ including Weibel-
Palade bodies (Figs. 4 and 5). The cells are routinely
examined by electron microscopy ofthin sections of
monolayers still attached to the culture flasks
(22, 24). However, we have developed means ofex-
aminingthe cells inculture withoutremoval fromthe
culture flasks by additional techniques including
freeze-fracture of monolayers, scanning electron
microscopy, and examination of surface replicas
(25). Thus, we are now able to recognize avariety of
views of endothelial cells. In addition, our cultures
possess functional aspects characteristic of en-
dothelial cells. The cells possess converting enzyme
activity as demonstrated using [125I]Tyr8-bradykinin
as substrate (22, 26, 27) and a variety of synthetic
substrates (please see accompanying paper). In
addition, the cells are reactive with antibodies to
angiotensin converting enzyme as can be shown
using immunofluorescence microscopy and im-
munocytochemistry (22). Usingthe lattertechnique,
we were able to localize angiotensin converting en-
zyme on the plasma membrane and caveolae of en-
dothelial cells in culture, a result which is in accord
with our previous demonstration ofangiotensin con-
verting enzyme on the luminal surface ofpulmonary
endothelial cellsin situ. Bovine endothelial cells also
react with antibodies to human factor VIII and a2-
macroglobulin, and this we have demonstrated by
immunofluorescence (24).
Synthesis of Prostaglandins by Pulmonary
Endothelial Cells
Resultsofourstudies showthatbovine pulmonary
artery endothelial cells are capable offorming pros-
taglandins and related substances from 1-14C-
arachidonate. Using EM autoradiography of cells
incubated with 3H-acetyl salicylate (a specific in-
hibitor of prostaglandin endoperoxide synthase) we
were able to show that the enzyme is situated on the
endoplasmic reticulum (4, 5, 28). PGE2 is the major
metabolite. A substance which co-chromatographs
with 6-keto-PGFia, a breakdown product ofPGI2, is
also formed, but in highly variable quantities. Syn-
thesisofPGI2 byendothelial cells hasbeendescribed
by a number of other laboratories recently (7). It is
likely that part or all of the PGI2 formed by lungs
arises from endothelial cells. Synthesis of PGI2 by
pulmonary endothelial cells, along with their ability
to degrade ADP (please see below), may account in
large part for the capacity of endothelial cells to
prevent or inhibit platelet aggregation. We were sur-
prised to find that PGB2 occurs as a major product.
Conceivably, PGB2 is formed from PGE2 during ex-
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FIGURE 2. Phase contrast micrograph ofcow pulmonary artery endothelial cells after 21 hr in culture.
The cells form a cluster of ca. 100 cells per cluster. x 150.
FIGURE 3. Confluent monolayer (ca. 4 x 104cells/cm2) ofcowpulmonary arteryendothelial cells. Phase
contrast. x 750.
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175FIGURE 4. Electron micrographs ofcalfpulmonary artery endothelium sectioned transversely including
a portion ofthe plastic culture flask on which the cells were growing (F). The boundary between the
flask and the cell is delineated by a fine dense line indicated by an arrow (probably formed from
components ofFCS) (see also Fig. 5). (a) Overall appearance ofa monolayer in transverse section,
illustratingthecontact inhibition betweenneighboringcells, x 1680. Mainbodyofthecellcontaining
rough (*) and smooth ER. Golgi complexes (G) arefrequentlyfound around the nucleus (N). x 8800.
Thick portion of the cell in the region of the nucleus and the slender peripheral extensions. These
extensions do not contain abundant endoplasmic reticulum but are characterized by numerous
microtubules and microfilaments. Caveolae (arrowheads) occur on both the peripheral and central
portions of the cells. x 5500. This figure is reproduced with permission from Ryan et al. (24).
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FIGURE 5. Thin section of endothelial cell showing Weibel-Palade bodies (arrows). x32,000.
traction. If so, the rate of PGE2 synthesis ap-
proached 0.5 ng/,ug of cell protein per hour. The
possibility should be considered that pulmonary ar-
tery endothelial cells have an unusually large capac-
ity for synthesizing PGE2, a vasodilator thought to
prevent or lessen hypoxic pulmonary vasoconstric-
tion. Our results indicate that pulmonary endothelial
cells can account for part of the efflux of prosta-
glandin-like substances from embolized or anaphy-
lactic lungs. However, our results provide no infor-
mation on the cellular origins of thromboxane A2,
likely to be a primary mediator ofanaphylaxis, or of
substances such as 15-ketodehydro metabolites of
PGE2 and PGF2a, all compounds which may occurin
lung venous effluent in much higher concentrations
than those ofPGE2 and PGF2a. Previously, we have
shown that endothelial cells in culture cannot de-
grade PGFia and El, excellent substrates for 15-
OH-dehydrogenase (3).
Endothelial Cells and the
Degradation of ADP
Intact blood vessel walls are known to have anti-
thrombotic properties, properties thought to be as-
sociated with the endothelial cell lining layer. As
mentioned above, it has recently been shown that
endothelial cells in culture can synthesize pros-
tacyclin (PGI2), a substance which can prevent
platelet aggregation and which can also disaggregate
platelet clumps. The lungs can also degrade the
potent, platelet aggregating agent adenosine 5'-
diphosphate (ADP) (29). Thus, in conjunction with
our studies on prostaglandins and related substances
we have examined pulmonary artery endothelial
cells in culture for ADPase activity. Approx. 106
cells were incubated with 14C- or 3H-ADP (with or
withoutcarrier) at37°C in5 mlofculturemedium. At
timed intervals, the incubation medium was exam-
ined by thin-layer chromatography. ADP at concen-
trations of3 x 10-7M to 3 x 10-5M wasfound to have
a half-life of approximately 3.5 min. The first prod-
uct formed was 5'-AMP, which was itselfdegraded
to yield adenosine and inosine. Adenosine did not
accumulate in the medium but was taken up by the
cells and incorporated into ADP and then into ATP.
In a second series of experiments, endothelial cells
were removed from their flasks with a rubber
policeman and homogenized. Subcellular fractions
were prepared by differential centrifugation.
ADPaseactivityoccurred mostabundantly inthemi-
crosomalfraction, thefractionalsoenriched interms
of angiotensin-converting enzyme (ACE). ACE is
known to occur as a component ofthe plasma mem-
brane of endothelial cells (24). Thus, pulmonary
endothelial cells can act to prevent intravascular
thrombosis by degrading ADP. The ADPase activity
is probably a component of the cell membrane.
SynthesisofAngiotensin-ConvertingEnzyme
by Endothelial Cells in Culture
Recently we undertook a study to determine
whether endothelial cells in culture synthesize an-
giotensin converting enzyme, or whether they
merely provide highly specific receptors for the en-
zyme. Previously, we have shown that endothelial
cells from cow, pig, rabbit and rat possess angioten-
sin converting enzyme, and we have shown that the
enzyme occurs along the plasma membrane and as-
sociated caveolae (22, 27, 30). Further, we have
shown that the angiotensin converting enzyme ac-
tivity persists through more than 50 passages (3).
Initially, we took these data to mean that endothelial
cells in culture are capable of synthesizing
angiotensin-converting enzyme. However, all ofour
April 1980
.....
177FIGURE 6. Enface section ofcalfpulmonary endothelial cell spanning the cell from the culture flask (F)
to the nucleus. The plane of section has grazed the nuclear envelope revealing nuclear pores
(arrowheads) and also grazed the plasma membrane revealing abundant caveolae (*). In addition to
elongated mitochondria (M), the cytoplasm contains large numbers of whorled polyribosomes
(arrows) attached tothe cisternae oftheendoplasmic reticulum. The inset shows anenlargementofa
portion ofthefield showingthe spiral arrangement ofribosomecomplexes. x 22,000; inset x 75,000.
Reproduced with permission from Ryan et al. (24).
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taining fetal calf serum (FCS) at 20 to 30% v/v FCS.
FCS is a rich source of angiotensin-converting en-
zyme; hence it seemed possible that endothelial cells
provide receptors for, but do not synthesize,
angiotensin-converting enzyme. To resolve this
problem, we have obtained cultures of bovine pul-
monary endothelial cells in FCS previously treated
by heatingat56°C, amaneuverreported toinactivate
angiotensin converting enzyme (31). The primary
cultures were propagated through four passages,
such that the average progeny in the fourth genera-
tion ofeach cell inthe original isolate was 6,400. The
cells were assayed by using [3H]benzoyl-Phe-Ala-
Proas substrate (32). The specificityofthe assay was
tested by using SQ 14,225 (10-5 M and 10-6 M), a
specific inhibitorofangiotensin converting enzyme.
Enzyme activity per cell was remarkably con-
stant, although there was a tendency for cell size to
increase along with, in the fourth generation, an in-
crease ofenzyme activity per cell. Under the condi-
tions of these experiments, there was a 12,428-fold
increase inangiotension convertingenzyme activity.
Thus, these results support the concept that bovine
pulmonary artery endothelial cells in culture are
capable of specific protein synthesis. Electron
micrographs ofgrazingsections ofthecells inculture
suggest that the cells appear to have the subcellular
machinery (extensive rough endoplasmic reticulum
and polyribosomes [Fig. 6]) to synthesize a complex
glycoprotein such as angiotensin converting enzyme
(24).
Concluding Remarks
As described above, techniques for the isolation
and culture of endothelial cells from bovine pulmo-
nary artery have been established. These cultures
have provided useful information on specific
metabolic activities ofpulmonary endothelium, and
have the advantage that large quantities ofcells can
be obtained inoriginal isolates. Inaddition, antigenic
sites of bovine cells appear to cross-react with an-
tibodiesto humanantisera. However, thetechniques
are not suitable for obtaining endothelial cells from
small animals. Moreover, endothelial cells of pul-
monary artery and those ofthe microvascular bed of
the lungs in situ differ in terms of structure. In addi-
tion, the smallcaliberandlarge extentofsurface area
ofthe pulmonary microcirculation make itlikely that
processing ofblood-borne substrates such as angio-
tensin, bradykinin, adenine nucleotides and amines
is most likely to take place atthe level ofthe smallest
vessels. We have, therefore, developed a technique
forobtaining endothelial cells from the lungs by vas-
cular perfusion with collagenase (500 units/ml) in
Hepes buffered salt solution.
Although one can readily isolate and culture en-
dothelial cells from pulmonary artery of, e.g., cow
(22, 24, 27), and one can readily isolate and culture
endothelial cells from human umbilical vein (3, 16),
we believe that our newly developed techniques for
obtaining endothelium from the lungs of small ani-
mals by vascular perfusion may have at least two
effects that will accelerate the pace and broaden the
scope of studies on specific metabolic functions of
the lungs. Firstly, the vast preponderance of studies
onthe possible metabolic functions ofthe lungs have
been performed using small animals; animals in
which it is virtually impossible to obtain an adequate
number of cells from mainstem pulmonary artery.
Secondly, although we and others have shown that
cells from main-stem pulmonary artery are capable
of metabolizing bradykinin, angiotensin, ADP,
adenosine, and biogenic amines, the general as-
sumption is that the processing of such substances
in vivo occurs most prominently at the level of the
microcirculation. Our new techniques of cell isola-
tion allow use ofsmall animals and therefore allow a
more direct comparison with previous functional
studies in which small animals, such as rats and
rabbits, have been used.
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